Search
Search

BrdU Labeling & Detection Cell Proliferation Protocol |
BrdU (5-bromo-2’-deoxyuridine) is a thymidine analog used in DNA synthesis–based cell proliferation assays. The BrdU assay principle involves the incorporation of BrdU into newly synthesized DNA during cell division. BrdU labeling and detection are achieved by using an anti-BrdU antibody, which binds to the incorporated BrdU, allowing for the imaging and quantification of proliferating cells. This process, often referred to as BrdU staining/labeling, is a critical component of the BrdU cell proliferation assay protocol and is detailed here.
BrdU labeling is a method used to detect cell proliferation by incorporating bromodeoxyuridine (BrdU), a thymidine analog, into newly synthesized DNA during the S-phase of the cell cycle. This allows researchers to measure DNA synthesis and study cell cycle dynamics.
The BrdU assay is based on the incorporation of bromodeoxyuridine (BrdU), a thymidine analog, into newly synthesized DNA during the S-phase of the cell cycle. After incorporation, cells are fixed, and the DNA is denatured to expose the BrdU. Anti-BrdU antibodies are then used to detect and quantify the incorporated BrdU, allowing measurement of cell proliferation and DNA synthesis.
To detect BrdU, incubate cells with BrdU, fix them, denature the DNA, stain with anti-BrdU antibodies, and analyze using flow cytometry or fluorescence microscopy.
For Research Use Only. Not for use in diagnostic procedures.